NEW YORK, Feb. 7, 2022 /PRNewswire/ -- Attention Revance Therapeutics, Inc. ("Revance") (NASDAQ: RVNC) shareholders:
The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between November 25, 2019 and October 11, 2021.
If you suffered a loss on your investment in Revance, contact us about potential recovery by using the link below. There is no cost or obligation to you.
https://www.wongesq.com/pslra-1/revance-therapeutics-inc-loss-submission-form?prid=23352&wire=4
ABOUT THE ACTION: The class action against Revance includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) quality control deficiencies existed at the Company's manufacturing facility for DaxibotulinumtoxinA for Injection ("DAXI"); (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration ("FDA") would approve the DAXI Biologics License Application ("BLA") in its current form; (iii) accordingly, it was unlikely that the DAXI BLA would obtain FDA approval within the timeframe the Company had represented to investors; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
DEADLINE: February 8, 2022
Aggrieved Revance investors only have until February 8, 2022 to request that the Court appoint you as lead plaintiff. You are not required to act as a lead plaintiff in order to share in any recovery.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
View original content:https://www.prnewswire.com/news-releases/class-action-alert-the-law-offices-of-vincent-wong-remind-revance-investors-of-a-lead-plaintiff-deadline-of-february-8-2022-301476057.html
SOURCE The Law Offices of Vincent Wong
